CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
0.7689
+0.0190 (2.53%)
Apr 22, 2025, 11:47 AM EDT - Market open
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $61.59 million as of April 22, 2025. Its market cap has decreased by -55.85% in one year.
Market Cap
61.59M
Enterprise Value
-28.84M
1-Year Change
-55.85%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $61.59M, a decrease of -86.75%. That is a compound annual growth rate of -19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 60.10M | -25.43% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |